BCL2L10 and melanoma: As Bcl2L10 hasbeen reported to exert its antiapoptotic activity in breast cancer modelsthrough inhibition of calcium release from the endoplasmic reticulum[12], we firstlycharacterized the contribution of Bcl2L10 overexpression tocalcium release in melanoma model.